Biotronik's rate-adaptive pacemakers get US clearance:
This article was originally published in Clinica
Executive Summary
Biotronik has obtained FDA approval to launch its Actros family of rate-adaptive single and dual chamber pacemakers. The 6mm wide device can switch modes within one cycle to correct atrial arrhythmia, and uses 50% less power than earlier devices, says the company.